ledipasvir

Gilead’s Hepatitis C Combination Wins EU Agency Backing
Bloomberg
Fri, 09/26/14 - 09:02 am
Gilead Sciences
hepatitis C
Europe
Sovaldi
ledipasvir
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
MannKind
Alkermes
Gilead Sciences
ledipasvir
AbbVie
Afrezza
aripiprazole lauroxil
Pharmacyclics
Imbruvica
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wed, 02/19/14 - 09:26 am
Regeneron
Eylea
Gilead Sciences
ledipasvir
Sovaldi
hepatitis C
Cangrelor
The Medicines Company
Can Gilead's $1,000 Pill Eradicate Hepatitis C?
Forbes
Thu, 12/19/13 - 11:35 am
Gilead
hepatitis C
Sovaldi
ledipasvir
Gilead to seek okay for combo hepatitis C pill in Q1
Reuters
Wed, 12/18/13 - 10:15 am
hepatitis C
Gilead Sciences
Sovaldi
ledipasvir
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thu, 05/2/13 - 10:28 am
hepatitis C
Gilead
ledipasvir
sofosbuvir
Gilead's HCV Study to Continue
Yahoo/Zacks
Tue, 04/2/13 - 10:10 am
hepatitis C
Gilead
sofosbuvir
ledipasvir